Advanced Therapy Medicinal Products: how to bring cell-based medicinal products successfully to the market
11 September 2014
Maritim Internationales Congress Centrum, Dresden, GERMANY
This workshop is co-organized by the European Medicines Agency’s Committee for Advanced Therapies (CAT) and the German Society for Transfusion Medicines and Immunohematology (DGTI) in collaboration with the German Stem Cell Network (GSCN) with the aims to bringing together industry, academia, hospitals and regulators to discuss how to progress forward the development and authorisation of advanced-therapy medicinal products (ATMPs).
It features presentations from CAT members, EMA and ATMP developers from industry, hospitals and academia, and includes the lively panel debates and direct interactions with the representatives from CAT and EMA .
The workshop will be of interest to all ATMP developers: industry, including SMEs; academics from
gene and cell therapy communities; healthcare professionals in the field; patient associations;
regulatory professionals; corporate decision-makers; and regulators.
08:30-09:15: Development and authorisation of cell-based ATMPs in the EU
09:15-10:10: Classification of ATMPs
10:30-12:00: Cell-based therapies for cardiac repair
12:30-13:00: Open forum Discussion with CAT
Maritim Internationales Congress Center
For registration to the Workshop, use the online registration on the website of the DGTI Annual